What does “PSMA” actually mean?
PSMA stands for Prostate-Specific Membrane Antigen. Despite the name, it isn't the prostate itself — it's a protein that sits on the surface of most prostate cancer cells.
Picture every cancer cell wearing a tiny flag. A PSMA scan uses a special tracer that seeks out those flags, making the cells “light up.” The more PSMA a cell carries, the easier it is to find.
Two technologies, one map
PET (Positron Emission Tomography) shows where the tracer collects. CT (or occasionally MRI) shows your anatomy.
Together they create a detailed map of where prostate cancer may be. Unlike a regular CT or bone scan — which mostly show changes caused by cancer — PSMA PET often detects the cancer cells themselves.
How the scan works
A tiny injection
A very small amount of radioactive tracer goes into a vein. The radiation is similar to many other imaging tests and fades naturally over time.
Wait about an hour
The tracer travels through your bloodstream, hunting for PSMA. Cancer cells absorb it far more than normal tissue does.
The scan
You lie comfortably for about 20–30 minutes while the scanner takes pictures. You simply stay still — most people find it completely painless.
More sensitive than the older scans
Traditional imaging
Still useful — but they can miss small or early disease.
PSMA PET can often find
Finding cancer earlier often leads to better treatment planning.
When might your doctor recommend one?
A PSMA PET scan isn't necessary for everyone. It's most valuable when the result is likely to change a treatment decision. Three common situations:
Before treatment
For newly diagnosed intermediate- or high-risk cancer, it checks whether disease has spread beyond the prostate — guiding surgery, radiation or other choices.
Rising PSA after treatment
Called biochemical recurrence. Even when PSA is very low and older scans look normal, PSMA PET can often locate where cancer has returned — a major advance in care.
Advanced disease
If cancer has already spread, it helps measure the extent of disease, monitor response to treatment, and decide whether additional therapies may help.
A sample PSMA PET report
This is an illustrative example — not a real patient. Click any colored term to see what it means, right here on the report.
EXAM DATE: 00/00/0000 · PSA: 0.42 ng/mL
Following IV administration of the radiotracer (F-18 piflufolastat), whole-body PET/CT images were obtained after a ~60-minute uptake period.
Expected physiologic uptake is noted in the salivary glands, kidneys, liver, and bladder.
There is focal, intensely PSMA-avid uptake in the left prostate bed SUVmax 14.2.
A single left external iliac lymph node is avid SUVmax 6.8, measuring 7 mm.
No osseous metastasis is identified. Overall pattern: miTNM = miT2 N1 M0, PSMA-RADS 5.
1. PSMA-avid disease in the left prostate bed with a single avid pelvic lymph node — consistent with locoregional recurrence.
2. No distant osseous or visceral metastasis. Correlate with PSA and prior pathology.
Illustrative example for education only — not a diagnosis. Every real report is read by a physician trained in nuclear medicine.
Common terms, decoded
The words that show up on almost every PSMA PET report. Tap any term to see what it means in everyday language.
The honest answers
Does a bright spot always mean cancer?+
Not always. Normal organs — salivary glands, kidneys, liver, small intestine and bladder — naturally absorb the tracer, and some non-cancerous conditions can light up too. That's why scans are interpreted by physicians specially trained in nuclear medicine and radiology.
Can a PSMA scan find every cancer?+
No imaging test is perfect. Some prostate cancers make very little PSMA and may not show well, and very tiny clusters of cells can be too small to detect. That's why doctors combine imaging with PSA levels, biopsy results, pathology and the rest of your clinical picture.
Are there side effects?+
Side effects are uncommon. The tracer doesn't usually cause allergic reactions, and most people feel nothing unusual after the injection. The radioactive material leaves the body naturally through urine over the next day — your imaging center may simply suggest drinking extra fluids.
Can it replace a biopsy?+
No. A biopsy is still the only way to confirm prostate cancer. PSMA PET helps show where cancer may be and whether it has spread, but it can't replace examining tissue under a microscope.
Does insurance cover it?+
Coverage has expanded dramatically. In the United States, Medicare and many private plans now cover PSMA PET when it meets established medical guidelines. Coverage varies with your diagnosis, prior treatment and plan — your doctor's office can usually help determine whether authorization is needed.
What happens after the scan?+
Your team combines the results with your PSA, Gleason Grade Group, biopsy findings, MRI (if available), overall health and treatment goals. The scan is one important piece of the puzzle — not the entire picture. You can usually return to normal activities right away.
From finding cancer to treating it
PSMA is doing more than improving pictures. Scientists now use the same PSMA “target” to deliver treatment directly to prostate cancer cells.
One example is Pluvicto® (lutetium Lu-177 vipivotide tetraxetan) — a therapy that attaches to PSMA and delivers radiation right to the cancer while limiting damage to healthy tissue.
Theranostics
Combining a diagnostic tracer with a matched therapy aimed at the same target. As imaging and treatment keep improving together, PSMA has become one of the most exciting advances in prostate cancer care.
Key takeaways
Among the most accurate imaging tests available for prostate cancer.
Detects cancer earlier and more precisely than many older methods.
Most helpful for higher-risk new diagnoses, rising PSA, and advanced disease.
One important piece — read alongside PSA, biopsy, MRI and your goals.
The goal of a PSMA PET scan isn't simply better pictures — it's helping every patient receive the right treatment at the right time.
Have questions about your scan?
Understanding your results is easiest when discussed with your healthcare team. PCRI's free Helpline can help you make sense of a report and your options — no cost, no pressure.